MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Epizyme Company Profile (NASDAQ:EPZM)

Consensus Ratings for Epizyme (NASDAQ:EPZM) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $35.50 (52.49% upside)

Analysts' Ratings History for Epizyme (NASDAQ:EPZM)
Show:
DateFirmActionRatingPrice TargetActions
6/23/2015HC WainrightReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015MizuhoReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2015Citigroup Inc.Reiterated RatingHold$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015Citigroup Inc.Boost Price TargetNeutral$23.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2015HC WainrightReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Citigroup Inc.DowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015JMP SecuritiesBoost Price TargetMarket Outperform$40.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2015MizuhoReiterated RatingBuy$35.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Citigroup Inc.Reiterated RatingBuy$40.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/12/2014MizuhoInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2014HC WainrightBoost Price TargetBuy$40.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014HC WainrightInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/15/2013Citigroup Inc.Reiterated RatingBuy$42.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2013 forward)